75 related articles for article (PubMed ID: 8195834)
41. [Clinical laboratory approach in estimating the effective dosage of cefamandole].
Uete G; Matsuo K; Uete T
Jpn J Antibiot; 1988 Jun; 41(6):631-40. PubMed ID: 3221428
[TBL] [Abstract][Full Text] [Related]
42. Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci.
Toma E; Barriault D
J Clin Microbiol; 1995 Jul; 33(7):1712-5. PubMed ID: 7665633
[TBL] [Abstract][Full Text] [Related]
43. Brodimoprim synergy against Enterococcus faecalis evaluated in vitro.
Richards RM; Xing JZ
J Antimicrob Chemother; 1996 Jul; 38(1):27-37. PubMed ID: 8858454
[TBL] [Abstract][Full Text] [Related]
44. Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.
Inoue M; Okamoto R; Okubo T; Inoue K; Mitsuhashi S
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():45-51. PubMed ID: 1399950
[TBL] [Abstract][Full Text] [Related]
45. Pefloxacin: evolution of in vitro activity during 18 months of use in an intensive care unit.
Tigaud S; Marcatello A; Gille Y; Robert D; Vincent P
Drugs Exp Clin Res; 1985; 11(3):169-76. PubMed ID: 3869804
[TBL] [Abstract][Full Text] [Related]
46. In vitro activity of a polyhexanide-betaine solution against high-risk clones of multidrug-resistant nosocomial pathogens.
López-Rojas R; Fernández-Cuenca F; Serrano-Rocha L; Pascual Á
Enferm Infecc Microbiol Clin; 2017 Jan; 35(1):12-19. PubMed ID: 27004429
[TBL] [Abstract][Full Text] [Related]
47. Bactericidal activity of citrate against Gram-positive cocci.
Lee YL; Thrupp L; Owens J; Cesario T; Shanbrom E
Lett Appl Microbiol; 2001 Nov; 33(5):349-51. PubMed ID: 11696094
[TBL] [Abstract][Full Text] [Related]
48. [Bacteriological study on cefadroxil in vitro. Correlation between diameter of inhibition zone and inhibitory concentration (author's transl)].
Grimm H
Arzneimittelforschung; 1980; 30(2):301-3. PubMed ID: 6821594
[TBL] [Abstract][Full Text] [Related]
49. Bactericidal effect of ultraviolet C (UVC), direct and filtered through transparent plastic, on gram-positive cocci: an in vitro study.
Rao BK; Kumar P; Rao S; Gurung B
Ostomy Wound Manage; 2011 Jul; 57(7):46-52. PubMed ID: 21904015
[TBL] [Abstract][Full Text] [Related]
50. Penetration of brodimoprim into human neutrophils and intracellular activity.
Braga PC; Dal Sasso M; Maci S; Bondiolotti G; Fonti E; Reggio S
Antimicrob Agents Chemother; 1996 Oct; 40(10):2392-8. PubMed ID: 8891150
[TBL] [Abstract][Full Text] [Related]
51. Trimethoprim resistance in gram-negative bacteria isolated in South Africa.
Wylie BA; Koornhof HJ
J Antimicrob Chemother; 1989 Dec; 24(6):973-82. PubMed ID: 2621180
[TBL] [Abstract][Full Text] [Related]
52. [Polycenter evaluation of the break-point system].
Casella P; Vaiani R; Sala MR; Cristiano L; Grigis A; Mancioppi GL; Melotti D
Quad Sclavo Diagn; 1985 Mar; 21(1):10-22. PubMed ID: 3903830
[TBL] [Abstract][Full Text] [Related]
53. Influence of subinhibitory concentrations of brodimoprim and trimethoprim on the adhesiveness, hydrophobicity, hemagglutination and motility of Escherichia coli.
Braga PC; Dal Sasso M; Maci S; Reggio S; Piatti G
Chemotherapy; 1995; 41(1):50-8. PubMed ID: 7875023
[TBL] [Abstract][Full Text] [Related]
54. Correlation between reduction of surface hydrophobicity of S. aureus and the decrease in its adhesiveness induced by subinhibitory concentrations of brodimoprim.
Braga PC; Reggio S
Pharmacol Res; 1995 Nov; 32(5):315-9. PubMed ID: 8868063
[TBL] [Abstract][Full Text] [Related]
55. Susceptibility of various microorganisms to chlorhexidine.
Emilson CG
Scand J Dent Res; 1977 May; 85(4):255-65. PubMed ID: 266752
[TBL] [Abstract][Full Text] [Related]
56. Microbiological conclusions.
Jones RN
Drugs; 1991; 42 Suppl 3():22-4. PubMed ID: 1726204
[No Abstract] [Full Text] [Related]
57. In vitro brodimoprim activity on nosocomial bacterial strains.
Nicoletti P; Novelli A; Periti P
J Chemother; 1993 Dec; 5(6):430-4. PubMed ID: 8195834
[TBL] [Abstract][Full Text] [Related]
58. In vitro brodimoprim activity on bacterial strains.
Benoit-Lemercier C; Bergogne-Bérézin E; Joly-Guillou ML
J Chemother; 1993 Dec; 5(6):435-43. PubMed ID: 8195835
[TBL] [Abstract][Full Text] [Related]
59. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
60. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
